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Previous studies have indicated that PsaR of Streptococcus pneumoniae is a manganese-
dependent regulator, negatively affecting the expression of at least seven genes. Here, we
extended these observations by transcriptome and proteome analysis of psaR mutants in strains
D39 and TIGR4. The microarray analysis identified three shared PsaR targets: the psa operon,
pcpA and prtA. In addition, we found 31 genes to be regulated by PsaR in D39 only, most
strikingly a cellobiose-specific phosphotransferase system (PTS) and a putative bacteriocin
operon (sp0142–sp0146). In TIGR4, 14 PsaR gene targets were detected, with the rlrA
pathogenicity islet being the most pronounced. Proteomics confirmed most of the shared gene
targets. To examine the contribution of PsaR to pneumococcal virulence, we compared D39 and
TIGR4 wild-type (wt) and psaR mutants in three murine infection models. During colonization, no
clear effect was observed of the psaR mutation in either D39 or TIGR4. In the pneumonia model,
small but significant differences were observed in the lungs of mice infected with either D39wt or
DpsaR: D39DpsaR had an initial advantage in survival in the lungs. Conversely, TIGR4DpsaR-
infected mice had significantly lower bacterial loads at 24 h only. Finally, during experimental
bacteraemia, D39DpsaR-infected mice had significantly lower bacterial loads in the bloodstream
than wt-infected mice for the first 24 h of infection. TIGR4DpsaR showed attenuation at 36 h
only. In conclusion, our results show that PsaR of D39 and TIGR4 has a strain-specific role in
global gene expression and in the development of bacteraemia in mice.
INTRODUCTION
Streptococcus pneumoniae encounters different environ-
ments during its life cycle: in most cases it inhabits the
human nasopharynx, where it resides asymptomatically,
but it can also spread through the body, causing severe
infections (Bogaert et al., 2004). What exactly triggers the
pneumococcus to cause infections at these sites in the body
is poorly understood. In response to environmental
changes, the transcriptional programme is likely to change,
which is considered to be niche-specific and can result in
expression of distinct virulence factors.
Manganese ions (Mn2+) are important for bacterial life,
for instance serving as cofactors for metalloenzymes. The
function of these metalloenzymes is widespread among
bacterial cellular processes, such as glycolysis, gluconeo-
genesis and oxidative stress defence (Jakubovics &
Jenkinson, 2001). In the pneumococcus, involvement of
Mn2+ in competence has also been described (Dintilhac
et al., 1997), but most studies have focused on its
involvement in oxidative stress (Ibrahim et al., 2005;
Johnston et al., 2004; McAllister et al., 2004; McCluskey
et al., 2004; Paterson et al., 2006; Tseng et al., 2002). In the
latter process, Mn2+ serves as a cofactor for superoxide
Abbreviations: CSP, competence-stimulating pepide; PTS, phospho-
transferase system; SILAC, stable isotope labelling in cell culture.
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dismutase, an important enzyme that provides defence
against superoxide radicals (Archibald & Fridovich, 1981).
As the concentration of manganese is much higher in saliva
than in blood plasma (Chicharro et al., 1999), fluctuations
in the amount of this trace element might serve as a trigger
for expression of certain virulence factors.
Various transcriptional regulators have been described for
the pneumococcus (Hava et al., 2003b) and several large-
scale mutagenesis studies have identified a role in virulence
for these regulators (Chastanet et al., 2001; Hava & Camilli,
2002; Hemsley et al., 2003; Lau et al., 2001; Polissi et al.,
1998). One of them is encoded by psaR, a transcriptional
regulator responsive to Mn2+ and negatively affecting the
expression of the psa operon, pcpA, rlrA and prtA
(Johnston et al., 2006; Kloosterman et al., 2008).
Recently, the PsaR-binding sequence was identified in the
promoter region of psaBCA, prtA and pcpA, and a genome-
wide screen for this binding sequence did not show any
other putative targets (Kloosterman et al., 2008).
Moreover, it has been reported that regulation by PsaR is
opposite in reaction to two cations, namely repression in
high Mn2+ and derepression in high Zn2+ (Kloosterman
et al., 2008).
The pcpA gene encodes a choline-binding protein
(Sanchez-Beato et al., 1998) and rlrA encodes a transcrip-
tional regulator, which controls the expression of the rlrA
pathogenicity islet (Hava et al., 2003a). The psaBCA
operon encodes the Psa permease that transports the
cations Mn2+ and Zn2+ into the cell (Dintilhac et al.,
1997; Johnston et al., 2004, 2006; Lawrence et al., 1998;
McAllister et al., 2004). The permease has been implicated
in virulence and protection against pneumococcal infection
(Briles et al., 2000; Talkington et al., 1996). Moreover, PsaA
has been shown to bind to E-cadherin, a surface molecule
of the host cells (Anderton et al., 2007; Romero-Steiner
et al., 2003, 2006). PsaR homologues are found in other
streptococci, where they regulate homologues of psaBCA
and contribute to virulence (Hanks et al., 2006; Jakubovics
et al., 2000; Paik et al., 2003). The role of PsaR in
pneumococcal virulence has been investigated in the strain
EF3030 (serotype 19F) genetic background (Johnston et al.,
2006). During 7 days of colonization no difference between
the wild-type and its isogenic psaR mutant was observed,
while after 7 days of lung infection, the psaR mutant
was significantly attenuated compared to the wild-type
(Johnston et al., 2006).
In this study, we examined the effect of the deletion of psaR
on global gene and protein expression in two other
pneumococcal strains, D39 (serotype 2) and TIGR4
(serotype 4), using transcriptomics and proteomics.
Furthermore, we investigated the contribution of PsaR to
pneumococcal virulence in three murine infection models
representing the major phases in the life cycle of S.
pneumoniae: colonization, pneumonia and bacteraemia.
METHODS
Bacterial strains and media. The pneumococcal strains used in this
study are listed in Table 1; they were grown at 37 uC in Todd–Hewitt
yeast broth (THY), in chemically defined medium (CDM, recipe
available on request), or on Colombia base agar (Oxoid) supple-
mented with 5% sheep blood (Biotrading). Pneumococcal strains
were maintained in 10% (v/v) glycerol, 10% skim milk at 280 uC.
Escherichia coli DH5a (Stratagene) was grown in Luria broth at 37 uC
with shaking or on Luria broth agar. Media were supplemented with
antibiotics (50 mg ampicillin l21 and/or 20 mg trimethoprim l21)
when appropriate.
Construction of psaR mutants. The gene encoding psaR was
deleted from strain TIGR4 (sp1638) and D39 (spd1450) by allelic
replacement with the dfr13 cassette conferring trimethoprim
resistance (Adrian et al., 2000). To this end, psaR with 1000 bp of
upstream and downstream flanking sequences was amplified from
chromosomal TIGR4 DNA using primer pair psaRSacFw and
psaRKnpRv (all primers are listed in Table 2). This amplicon was
cloned into pBlueScript KS+ (Stratagene) using the SacII and KpnI
restriction sites. The coding sequence of psaR was deleted from the
plasmid by performing an inverse PCR with primer pair psaRNotFw
and psaRSalRv, amplifying the psaR-flanking sequences and
pBlueScript KS+ and introducing NotI and SalI restriction sites for
further cloning. This amplicon was ligated to the dfr13 cassette, which
was amplified from pKOT (Hendriksen et al., 2008a) with the primers
TmpSalFw and TmpNotRv, to create the knockout construct
pKOpsaR-T4, and transformed into E. coli DH5a. A 2620 bp linear
DNA fragment containing psaR-flanking DNA and dfr13 was
amplified from pKOpsaR-T4 using primer pair psaRSacFw and
psaRKnpRv. This PCR product was used to delete psaR from the
genome of S. pneumoniae TIGR4 by CSP-2-induced (100 ng ml21)
transformation. Transformants were selected on the basis of
trimethoprim resistance and were checked by sequencing for
recombination at the desired location on the chromosome, i.e.
replacement of psaR by dfr3 (which will be transcribed in the opposite
direction to psaR). Wild-type TIGR4 was subsequently transformed
with chromosomal DNA isolated from these DpsaR transformants to
rule out the possibility of any additional mutations on the
chromosome. The identical procedure was performed for the
construction of D39DpsaR, with the exception that the 39 chro-
mosomal region from TIGR4 of pKOpsaR-T4 was replaced by the
D39-specific 39 psaR region. This region differs between the two
Table 1. Pneumococcal strains used in this study
Strain Gene identifier Antibiotic resistance Reference
D39 wild-type – – NCTC 7466; serotype 2
D39DpsaR spd1450 Trimethoprim This study
TIGR4 wild-type – – ATCC BAA-334; serotype 4
TIGR4DpsaR sp1638 Trimethoprim This study
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strains: it contains an ISS element in TIGR4, and a small ORF
encoding a unique hypothetical protein in D39. Transformation of
D39 was induced with CSP-1 (100 ng ml21).
Transcriptional profiling of D39 and TIGR4 psaR mutants.
Microarray analysis was performed essentially as described by
Hendriksen et al. (2007, 2008a). In short, 500 ml CDM was
inoculated with 10–20 colonies from agar plates, and these cultures
were grown statically at 37 uC. Samples for RNA isolation were taken
when the cultures reached an optical density (OD600) of 0.2 (mid-
exponential growth). RNA was isolated and purified using the High
Pure RNA isolation kit (Roche Diagnostics) as described by
Hendriksen et al. (2007, 2008a). Contaminating genomic DNA was
removed by treatment with RNase-free DNase I (Roche Diagnostics).
RNA was isolated from three replicate cultures. Synthesis, subsequent
labelling of cDNA, and microarray hybridization were performed as
previously described (Hendriksen et al., 2007; Kloosterman et al.,
2006). In all cases, dye-swapping was performed with one of the three
biological replicates. Microarrays used in this study were constructed
as previously described (Hendriksen et al., 2007; Kloosterman et al.,
2006) and contain amplicons representing 2087 ORFs of S.
pneumoniae TIGR4 and 184 ORFs unique for S. pneumoniae R6, all
spotted in duplicate.
The microarray data have been deposited in the NCBI Gene
Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/
geo/) under GEO Series accession number GSE13505.
DNA microarray data analysis. Dual-channel array images were
acquired with a GeneTac LS IV confocal laser scanner (Genomics
Solutions) and analysed with ArrayPro 4.5 software (Media
Cybernetics). Spots were screened visually to identify those of low
quality. Slide data were processed using MicroPreP as previously
described (Garcia de la Nava et al., 2003; Hendriksen et al., 2007; van
Hijum et al., 2003). Prior to analysis, automatically and manually
flagged spots and spots with very low background-subtracted signal
intensity [5% of the weakest spots (sum of Cy3 and Cy5 net signals)]
were filtered out of all datasets. Spots with a signal in one channel and
no signal in the other were subjected to an empty-value assignment of
1%, after which net signal intensities were calculated using a grid-
based background subtraction. A grid-based Lowess transformation
was performed for slide normalization, negative and empty values
were removed, and outliers were removed by the deviation test.
Further analysis was performed using a Cyber-T Student’s t-test for
paired data (Long et al., 2001). For identification of differentially
expressed genes, only genes with a minimum of six reliable
measurements, a Bayesian P-value ,0.001, a false discovery rate
(FDR) ,0.05, and a standard deviation less than the ratio were
included. Since these criteria are purely a statistical measure of
differential gene expression and reproducibility across replicates, an
additional fold-change cut-off of 2 was applied.
Stable isotope labelling in cell culture (SILAC). For SILAC
experiments, D39 wild-type and psaR-mutant strains were inoculated
in THY and grown to mid-exponential phase. These cultures were used
to inoculate CDM, supplemented with both lysine and arginine as the
light (12C6 L-lysine,
12C6 L-arginine; psaR mutant) or heavy (
13C6 L-
lysine, 13C6 L-arginine; wild-type) isotopic counterparts. When these
cultures reached an OD600 of 0.2, they were diluted to an OD600 of 0.04
in fresh pre-warmed CDM with the appropriate heavy or light lysine
and arginine, and grown to an OD600 of 0.2. This was repeated until the
cells had been grown in heavy or light lysine- and arginine-containing
CDM for at least five or six generations. After the last generation, the
cells were harvested by centrifugation and washed once with PBS. Equal
amounts of heavy-labelled wild-type and light-labelled mutant cells
were combined and used for mass spectrometry. Bacterial pellets were
lysed in lysis buffer [7 M urea, 2 M thiourea, protease inhibitor mix
(Roche), pH 8.0]. Lysates were subjected to reduction and alkylation
using dithiothreitol and iodoacetamide before LysC and trypsin
digestion. Peptide mixtures were purified and desalted using C18-stage
tips. Peptide separation and sequence determination was performed
with a nano-high-performance liquid chromatography system (Agilent
1100 series) connected to a 7-T linear quadrupole ion trap ion
cyclotron resonance Fourier transform mass spectrometer (Thermo
Electron). Peptides were separated on a 15 cm 100 mm inner diameter
PicoTip emitter for online electrospray (New Objective) packed with
3 mm C18 beads (Reprosil, Dr Maisch GmbH) with a 60 min linear
gradient from 2.4 to 40% acetonitrile in 0.5% acetic acid at a flow rate
of 300 nl min21. The four most abundant ions were sequentially
isolated and fragmented in the linear ion trap by applying collisionally
induced dissociation. Proteins were identified using the MASCOT
search engine (Matrix Science) against the corresponding S. pneumo-
niae database. MSQuant was used for the quantification and
determination of peptide ratios between wild-type and psaR mutant.
A protein was considered differentially expressed when the results of
three technical replicates showed at least a 1.5-fold change in protein
abundance and a P-value ,0.05 (one-sample t-test).
Infection models. Nine-week-old female outbred CD-1 mice
(Harlan) were used for all infection models. Prior to the infection
experiments, D39 and TIGR4 (wild-type and psaR mutants) were
passaged in mice as described previously (Kerr et al., 2004). Cultures
of S. pneumoniae D39 and TIGR4 (wild-type and DpsaR) were grown
in THY broth to an OD600 of 0.3, and stored in aliquots in 10%
glycerol at 280 uC. Prior to infection, these aliquots were spun down
and bacteria were resuspended in sterile PBS to 106 c.f.u. in volumes
Table 2. Oligonucleotide primers used in this study
Primer name Sequence (5§–3§)* Restriction site Strain
psaRSacFw GCGCCCGCGGGGAATTTGCATCCTCTTCTCC SacII D39/TIGR4
psaRKnpRv GCGCGGTACCATATTGCCCATCAGCTTTCC KpnI TIGR4
psaRNotFw GCGCGCGGCCGCTCCTCAGTAACGACGAGGATTT NotI D39/TIGR4
psaRSalRv GCGCGTCGACGCAGGTCTATGCCAATTTCA SalI D39/TIGR4
TmpSalFw CGCGGTGGTCGACGGATTTTTGTGAGCTTGGACT SalI D39/TIGR4
TmpNotRv GGGGGGCCGCGGCCGCTTACGACGCGCATAGACG NotI D39/TIGR4
psaRKpnRv-D39 GAAAATGGTACCAGAGAGCAAGAGCCACTC KpnI D39
SeqTmpFw ATAAATGCGGACCGATTCC – D39/TIGR4
SeqTmpRv GCCTTCTTCCCAGTGCTTAAC – D39/TIGR4
*Restriction sites on oligonucleotide primers are underlined.
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Table 3. Differentially expressed genes/proteins in DpsaR of D39 and/or TIGR4
Ratios are given as log2-transformed expression of DpsaR/wild-type.
Identifier Gene Annotation (http://www.kegg.com) Microarray SILAC
TIGR4 D39 TIGR4 D39 TIGR4 D39
Upregulated
sp0232 spd0215 infA Translation initiation factor IF-1 2.4
sp0303 spd0277 bglA 6-Phospho-b-glucosidase 1.1
sp0306 spd0280 Transcriptional regulator, putative 1.2
sp0308 spd0281 PTS system, cellobiose-specific IIA component 1.5
sp0310 spd0283 PTS system, cellobiose-specific IIC component 1.2
– spd0322 cps2G Glycosyltransferase, group 1 family protein 4.5
sp0459 spd0420 pflB Formate acetyltransferase 0.8
sp0461 – rlrA Transcriptional regulator 2.7
sp0462 – rrgA Cell wall surface anchor family protein 3.1
sp0463 – rrgB Cell wall surface anchor family protein 3.7 2.0
sp0464 – rrgC Cell wall surface anchor family protein 3.7
sp0467 – Sortase SrtC, putative 2.5
sp0468 – Sortase SrtD, putative 2.6
sp0641 spd0558 prtA Serine protease, subtilase family PrtA 3.6 3.0 3.9
sp0869 spd0764 sufS Cysteine desulfurases, SufS subfamily protein 5.0
sp1244 spd1101 ftsY Signal recognition particle-docking protein FtsY 7.6
sp1517 spd1345 greA Transcription elongation factor GreA 2.9
sp1531 spd1360 Hypothetical protein 2.7
sp1636 spd1448 Rrf2 family protein 1.3
sp1637 spd1449 Hypothetical protein 1.4 1.2
sp1647 spd1460 pepO Endopeptidase O 0.6
sp1648 spd1461 psaB Manganese ABC transporter, ATP-binding protein 3.6 3.3
sp1649 spd1462 psaC Manganese ABC-transporter permease 2.8 2.4
sp1650 spd1463 psaA ABC transporter, substrate-binding lipoprotein 5.4 5.1
sp1805 spd1591 Hypothetical protein 0.6
sp1856 spd1637 Transcriptional regulator, MerR family 1.2
sp1857 spd1638 czcD Cation-efflux system protein 1.7
sp2136 spd1965 pcpA Choline-binding protein PcpA 4.0 4.6 7.4
sp2210 spd2037 cysK Cysteine synthase A 4.0
Downregulated
sp0112 spd0109 Polar amino acid transport system substrate-binding
protein
21.2
sp0138 spd0141 Hypothetical protein 21.7
sp0139 spd0142 Hypothetical protein 21.8
sp0140 spd0143 ugd UDP-glucose/GDP-mannose dehydrogenase 21.7
sp0141 spd0144 mutR Positive transcriptional regulator of MutA 21.2
sp0142 spd0145 Hypothetical protein 21.0
sp0143 spd0146 Hypothetical protein 21.9
sp0144 spd0147 Hypothetical protein 21.5
sp0145 spd0148 Hypothetical protein 22.0
sp0146 spd0149 Hypothetical protein 21.7
sp0148 spd0150 ABC transporter, substrate-binding protein 22.1
sp0524 spd0466 BlpT protein, fusion 21.5
sp0525 spd0467 blpS BlpS protein 21.4
sp0526 spd0468 blpR Response regulator BlpR (TCS13) 21.2
sp0527 spd0469 blpH Sensor histidine kinase BlpH, putative (TCS13) 21.1
sp0529 spd0471 blpB BlpC ABC transporter 21.5
sp0530 spd0472 blpA BlpA, pseudogene 21.5
sp0533 spd0046 blpK Bacteriocin BlpU (highly similar to sp0533) 21.5
sp0541 spd0046 blpO Bacteriocin BlpO (59 highly similar to sp0541) 21.5
sp0545 spd0473 blpY Immunity protein BlpY 22.4
sp0546 spd0474 blpZ BlpZ protein, fusion 21.2
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depending on the infection model used. Upon intranasal infection,
mice were anaesthetized with 2.5% (v/v) isoflurane/O2. At pre-
determined time points after infection, groups of mice were sacrificed
by cervical dislocation and samples of various sites were taken to
determine the bacterial load. During infection, signs of disease were
closely monitored. If animals reached a moribund state, they were
sacrificed by cervical dislocation and excluded from the experiment
prematurely. All animal experiments were performed with approval
from the Animal Experimentation Committee (DEC) of Erasmus
Medical Centre, Rotterdam, The Netherlands.
Colonization model of infection. In the colonization model, 10 ml
PBS containing 106 c.f.u. bacteria was administered to the nostrils of
groups of five mice as described previously (Hendriksen et al., 2008b;
Kadioglu et al., 2000). Due to this small volume, only the nose of the
mice becomes infected. Bacteria were recovered from the nasophar-
ynx by flushing the nose with 2 ml sterile PBS (Kerr et al., 2004), and
lungs were removed from the body and homogenized in 2 ml sterile
PBS using a hand-held homogenizer (Polytron PT 1200, Kinematica
AG). Viable bacteria from the nasal lavage fluid and homogenized
lung samples were counted by plating serial 10-fold dilutions on
Colombia blood agar plates. Time points for sampling were 30 min,
24 h, 48 h, 96 h and 192 h post-infection. The 30 min time point is
considered to be the start of the infection, and is therefore referred to
as t50. Bacteriology results are expressed as geometric mean±SEM.
Comparison of bacterial loads in the time-course experiment was
performed using a Student’s t-test with P,0.05 considered statist-
ically significant.
Pneumonia model of infection. In the pneumonia model, five mice
per group were infected with 50 ml PBS containing 106 c.f.u.
pneumococci as described previously (Hendriksen et al., 2008b).
Bacteria were recovered from the different sites as described above,
with the addition of a blood sample obtained by cardiac puncture.
Time points for sampling were 0, 12, 24 and 36 h post-infection.
Viable bacteria isolated from the nasal lavage fluid, homogenized
lungs and blood were quantified as described above. Bacteriology
results are expressed as geometric mean±SEM. Comparison of
bacterial loads in the time-course experiment was performed using
a Student’s t-test with P,0.05 considered statistically significant.
Bacteraemia model of infection. In the bacteraemia model, groups
of ten mice were infected in a tail vein with 106 c.f.u. resuspended in
100 ml sterile PBS as described previously (Hendriksen et al., 2008b).
Bacteria were recovered from the blood by a lateral tail vein puncture
from the same mouse at three predetermined time points after
infection (0, 12, 24 h) and by a cardiac puncture at the last time
point, 36 h. In addition, mouse survival times were scored, after
which analysis of survival times was performed using the log-rank test
with P,0.05 considered statistically significant.
RESULTS
Transcriptional analyses of DpsaR in D39 and
TIGR4
By means of microarrays analysis, we assessed which genes
were affected in expression due to the mutation of psaR in
two genetic backgrounds, i.e. D39 and TIGR4. To this end,
transcriptional profiles of wild-type strains were compared
to their isogenic DpsaR strains. These bacteria were grown
in chemically defined medium (CDM) and harvested at
mid-exponential growth phase. In all experiments, the psaR
mutant strains grew like the wild-type. The concentration
of Mn2+ in CDM is 180 mM, which is sufficient for PsaR
regulation (see Kerr et al., 2004, where 50 mM was used).
For comprehensibility, loci of D39 are referred to by the
TIGR4 gene identifiers (in Table 3 both annotations are
given). Comparison of transcriptional profiles of D39 and
TIGR4 wild-type with their DpsaR counterparts revealed 19
differentially expressed genes in TIGR4DpsaR, and 37 in
D39DpsaR. Of these, five genes were upregulated in both
TIGR4 and D39 psaR mutants, while only psaR itself was
downregulated in both strains (Fig. 1).
The genes that were differentially expressed in both
serotypes were all upregulated in the psaR mutant,
confirming the general role of PsaR as a transcriptional
repressor (Johnston et al., 2006; Kloosterman et al., 2008).
Among those were the previously described targets, the psa
operon (sp1648–sp1650), pcpA (sp2136) and prtA (sp0614).
Identifier Gene Annotation (http://www.kegg.com) Microarray SILAC
TIGR4 D39 TIGR4 D39 TIGR4 D39
sp0547 spd0475 Hypothetical protein 22.4
sp0664 spd0577 zmpB Zinc metalloprotease ZmpB, putative 20.8
sp0798 spd0701 ciaR DNA-binding response regulator CiaR 21.1
sp0925 spd0817 Hypothetical protein 21.4
sp1024 spd0910 glyA Serine hydroxymethyltransferase 21.1
sp1249 spd1107 GMP reductase 21.0
sp1458 spd1287 trxB Thioredoxin reductase 21.0
sp1543 spd1372 Glyoxalase family protein 21.5
sp1638 spd1450 psaR Iron-dependent transcriptional regulator, PsaR 22.7 22.0
sp1802 spd1588 Hypothetical protein 21.2
sp1804 spd1590 General stress protein 24, putative 21.3
sp1923 spd1726 ply Pneumolysin 21.0
sp2022 spd1831 PTS system, cellobiose-specific IIC component, putative 21.4
sp2023 spd1832 PTS system, cellobiose-specific IIB component, putative 21.2
Table 3. cont.
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In addition, sp1637, encoding a hypothetical protein of
unknown function, was found to be upregulated in the
psaR mutants of both strains (Table 3).
Four genes were found to be repressed by PsaR in D39 (i.e.
upregulated in D39DpsaR) only: sp0303, encoding 6-
phospho-b-glucosidase; sp0306, encoding a putative tran-
scriptional regulator; and two genes of a putative operon
encoding a cellulose-specific phosphotransferase system
(PTS) (sp0308 and sp0310).
Twenty-seven genes were downregulated in D39DpsaR.
This set of genes contained sp0112, predicted to encode an
amino acid substrate-binding protein; the transcriptional
regulator mutR (sp0141); a putative bacteriocin system
(sp0142–sp0146); the blp two-component system (TCS13;
sp0526–sp0527); the gene encoding response regulator CiaR
(sp0798); and glyA (sp1024) encoding serine hydroxy-
methyltransferase. The full set of differentially expressed
genes in D39 is listed in Table 3.
In addition to the common gene targets, nine genes were
specifically upregulated in the psaRmutant in TIGR4 (Fig. 1).
These included the rlrA pathogenicity islet (sp0461–sp0468)
as reported previously (Johnston et al., 2006); sp1636
(encoding an Rf2 family protein); and two adjacent genes,
encoding a MerR family transcriptional regulator (sp1856)
and czcD (sp1857), a Zn2+-efflux pump (Table 3).
Four genes were downregulated: guaC, encoding GMP
reductase (sp1249); ply, encoding pneumolysin (sp1923);
and two genes encoding the B and C components of a
putative cellobiose-specific PTS (sp2022 and sp2023). The
complete set of differentially expressed genes in
TIGR4DpsaR is given in Table 3.
Proteome analysis of DpsaR in D39 and TIGR4
To examine if the observed PsaR-mediated differences in
gene expression corresponded to changes in protein
expression, we performed SILAC for both wild-type strains
and their psaRmutants. To this end, wild-type and isogenic
DpsaR counterparts were cultured in the presence of stable
isotope-labelled (heavy, 13C6) or normal (light,
12C6) L-
lysine and L-arginine, respectively. Equal amounts of
bacteria were mixed and analysed by mass spectrometry,
after which changes in protein expression between wild-
type and isogenic DpsaR strains were derived from the
corresponding heavy to light peptide ratios.
In D39DpsaR, nine proteins were found to be more
abundant than in the wild-type (Table 3). Most pro-
nounced were FtsY, PsaA, SufS, Cps2G, CysK and PrtA, all
of which displayed expression levels at least eight times
higher in the psaR mutant than in the wild-type. No
proteins were identified that were less abundant in
D39DpsaR (Table 3).
In TIGR4DpsaR, six proteins were more abundant than in
the wild-type. Most pronounced were PcpA, PsaA and
RrgB, all with at least a fourfold increase in expression in
the psaR mutant (Table 3). Three proteins were less
abundant in TIGR4DpsaR, i.e. an ABC transporter of a
putative bacteriocin system (sp0148), TrxB and ZmpB
(Table 3).
PsaR does not contribute to pneumococcal
colonization
To assess the contribution of PsaR regulation to pneumo-
coccal virulence, we examined the phenotypes of the two
wild-type strains and their psaR mutants in three murine
models of infection. In the colonization model, both wild-
type D39 and TIGR4 were capable of extended colonization
of the murine nasopharynx for a period of 192 h. The level
of colonization was fairly consistent during this period,
varying between 104 and 106 c.f.u. ml21 (Fig. 2).
We did not observe a clear effect of the deletion of psaR on
the colonization ability of strains: comparable bacterial
loads of wild-type and mutant strains were found during
192 h of colonization, with bacterial loads between
2.56104 c.f.u. ml21 and 3.26105 c.f.u. ml21 for D39
wild-type and its isogenic psaR mutant, and between
1.36105 c.f.u. ml21 and 5.06105 c.f.u. ml21 for TIGR4
wild-type and its DpsaR derivative (Fig. 2a and b). The only
exception was a small but significantly higher load
(P50.0049) of D39DpsaR at 24 h (Fig. 2b).
PsaR is not required for pneumococcal
pneumonia
In the pneumonia model, we observed a similar trend in
bacterial loads of the nasopharynx as was observed in the
colonization model, although the actual numbers of
bacteria were lower. At 12 h of infection there was a small
but significantly higher nasopharyngeal load in mice
infected with D39DpsaR as compared to wild-type (data
not shown). For TIGR4 wild-type and DpsaR, small but
significant differences in bacterial load were observed
throughout the entire experiment (data not shown).
Fig. 1. Number of genes differentially expressed in D39DpsaR
and TIGR4DpsaR.
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Furthermore, bacterial loads in the nasopharynx were
comparable to those of the first 36 h in the colonization
model (data not shown).
We did not observe any clear difference in the bacterial
survival in the lungs between wild-type and psaR mutants
(Fig. 3a). However, immediately after infection (0 h) and
12 h post-infection, the lung homogenates of D39DpsaR-
infected mice had significantly higher bacterial loads than
those of wild-type infected mice: 1.26105 vs 6.36
104 c.f.u. ml21 at 0 h, and 1.56105 vs 5.86104 c.f.u.
ml21 at 12 h. This suggests that there might be an initial
positive effect of the psaR mutation, as the inoculum of the
wild-type contained (more than) twice as many bacteria as
that of the psaR mutant (1.26106 and 4.56105 c.f.u.
ml21, respectively).
In contrast, mice infected with the TIGR4 psaR mutant had
lower bacterial loads in the lungs compared to mice
infected with TIGR4 wild-type, although these differences
were only statistically significant at 24 h post-infection
(P50.0401) (Fig. 3b).
The number of bacteria that were able to reach the systemic
circulation was not significantly different between wild-
type and DpsaR in either D39 or TIGR4 (data not shown),
indicating that PsaR regulation is not required for the
transition from the lungs to the systemic circulation.
PsaR contributes to survival of pneumococci
during bacteraemia
The most prominent phenotype of the psaR mutants was
observed in the bacteraemia model of infection. D39 wild-
type-infected mice had significantly more bacteria in the
blood than the D39DpsaR-infected mice during the first
24 h of infection (Fig. 4a), while variation in the inocula
was marginal (1.66106 for wild-type and 1.46106 for
psaR mutant). In contrast, no differences were seen
between mice infected with TIGR4 wild-type and
TIGR4DpsaR during the first 24 h of infection. At 36 h
post-infection, however, TIGR4 wild-type-infected mice
had twice as many bacteria in the bloodstream (P50.0396)
(Fig. 4b).
In addition to the differences in bacterial load, we also
observed a difference in murine survival after infection
with D39 or TIGR4 in our bacteraemia model: all TIGR4-
infected mice (wild-type and DpsaR) survived, in contrast
to D39 wild-type infected mice, which died within 30 h. Of
the D39DpsaR-infected mice, three survived the experi-
ment. Consequently, the median survival time of
D39DpsaR-infected mice was significantly longer than that
of mice infected with its wild-type parental strain (the
median survival for DpsaR was 24 h and for wild-type 30 h,
with P50.0405 and hazard ratio51.866).
Fig. 3. Pneumonia model. Bacterial loads in lungs and blood of
mice infected with (a) D39 wild-type (&) and D39DpsaR (h), (b)
TIGR4 wild-type (&) and TIGR4DpsaR (h). *, P,0.05.
Fig. 2. Colonization model. Bacterial loads in the nasal lavage fluid
of mice infected with (a) D39 wild-type (&) and D39DpsaR (h),
(b) TIGR4 wild-type (&) and TIGR4DpsaR (h). *, P,0.05.
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DISCUSSION
During colonization and infection of the human host, S.
pneumoniae encounters fluctuating amounts of free Mn2+
in the different niches where the bacterium resides. Since
Mn2+ is required for several cellular processes, proper
regulation of manganese homeostasis is vital for pneumo-
coccal physiology and virulence. The transcriptional
repressor PsaR has been described to play an important
role in this process, at least in the genetic background of
strain EF3030 (serotype 19F) (Johnston et al., 2006).
However, we and others have previously shown that, even
though transcriptional regulators themselves appear to be
conserved between S. pneumoniae strains, they often have a
strain-specific impact on global transcription and virulence
(Hendriksen et al., 2007; Blue & Mitchell, 2003; McCluskey
et al., 2004). To examine whether a similar strain specificity
holds true for PsaR, we identified its targets and its
contribution to experimental virulence in two additional
strains, TIGR4 and D39.
We used a combination of transcriptional and proteome
analyses for the identification of PsaR targets. Observed
discrepancies between these two approaches could be the
result of several factors, such as low levels of gene
expression, protein instability, or post-translational regu-
lation. The previously reported PsaR targets, the Psa
operon, pcpA and prtA (Johnston et al., 2006; Kloosterman
et al., 2008), were confirmed in TIGR4 and D39 by both
transcriptomics and proteomics. In addition, we found
sp1637, encoding a hypothetical protein, to be upregulated
in both psaR mutants. Since the latter gene is located
directly upstream of psaR (sp1638), we cannot entirely
exclude the possibility that the derepression of sp1637 is
caused by transcriptional read-through of the trimetho-
prim-resistance cassette used to create the psaR knockout.
We have previously shown that the common PsaR target
pcpA is required for adherence to the human Detroit
epithelial cell line and that the expression of this gene is
also directly positively regulated by the nutritional
regulator CodY (Hendriksen et al., 2008a). The inability
of the codY mutant to colonize the murine nasopharynx
underscored, albeit indirectly, the involvement of PcpA in
adherence and colonization. However, a recent study
showed that PcpA is not involved in colonization but has
a role in invasive disease (Glover et al., 2008). These
contradictory results are possibly due to different experi-
mental set-ups; however, the exact role of PcpA during
pneumococcal pathogenesis remains unclear.
In addition to the shared PsaR targets (i.e. the overlapping
genes between D39 and TIGR4), several genes were
differentially expressed in D39 or TIGR4 only. This
strain-specific differential expression might be due to
direct regulation by PsaR, but is more likely to be either an
indirect effect caused by an imbalance in Mn2+/Zn2+
homeostasis due to the lack of PsaR or, possibly,
downstream signalling of other regulators. Moreover, it
seems that this effect was more severe for D39, since more
genes and proteins were affected in their expression level in
this strain. Downstream regulation or a disturbed balance
in other cellular processes might be the cause of this
differential expression, since manganese cations have been
shown to be required for several bacterial cellular processes
(Jakubovics & Jenkinson, 2001). For example, manganese
cations have been shown to function as cofactors for
enzymes in glycolysis, amongst others 6-phospho-b-
glucosidase (Varrot et al., 1999). The genes encoding
6-phospho-b-glucosidase and a PTS downstream of it
(sp0303, sp0306 and sp0308), were upregulated in
D39DpsaR, in line with indirect regulation. However, in
D39 these genes are strongly downregulated in the presence
of Zn2+, which is not in agreement with the opposite effect
of Mn2+ and Zn2+ on PsaR regulation (Kloosterman et al.,
2008).
In D39DpsaR, the gene ciaR, involved in competence
development, was upregulated. It has been reported that
Mn2+ is required for genetic transformation (Dintilhac
et al., 1997), suggesting that downregulation of this gene
might be an indirect effect of the psaR mutation. Several
other systems were downregulated in D39DpsaR alone,
such as a putative bacteriocin system (sp0142–sp0146), the
blp bacteriocin system, and the blp two-component system
(TCS13). The genes sp0142–sp0146 have also been shown
to be regulated by the nutritional regulator CodY in D39
(Hendriksen et al., 2008a). Possibly, the downregulation of
the blp bacteriocin genes is due to downregulation of the
blp two-component system (Dawid et al., 2007; de Saizieu
et al., 2000).
Fig. 4. Bacteraemia model. Bacterial loads in blood of mice
infected with (a) D39 wild-type (&) and D39DpsaR (h), (b) TIGR4
wild-type (&) and TIGR4DpsaR (h). *, P,0.05.
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Notably in TIGR4, a MerR family regulator (sp1856) and
czcD (sp1857), encoding a Zn2+-efflux system, were
upregulated in the psaR mutant. These two genes have
also been shown to be upregulated in the presence of Zn2+,
underscoring the reported opposite effect of Mn2+ and
Zn2+ on PsaR regulation (Kloosterman et al., 2008). The
czcD gene has recently been shown to be regulated by SczA
(sp1858) in reaction to increasing cellular zinc concentra-
tions (Kloosterman et al., 2007), but this efflux system
might also be involved in Mn2+ homeostasis. This again
indicates that these regulatory systems of cation homeo-
stasis are intertwined (Kloosterman et al., 2008).
The expression of ply (encoding the pneumococcal toxin
pneumolysin) was downregulated as a result of the psaR
mutation during in vitro growth in TIGR4 only. If this
downregulation also occurred during our infection experi-
ments, it did not have a large effect on experimental
virulence of the TIGR4 strain, as the DpsaR mutant was as
virulent as the wild-type in all our infection models. Only
at 24 h post-infection during experimental pneumonia did
mice infected with the psaRmutant have significantly lower
bacterial loads in the lungs compared to those infected with
the wild-type.
A role for PsaR in virulence has been reported in a strain
EF3030 genetic background (Johnston et al., 2006). During
7 days of colonization no difference between the wild-type
and isogenic psaR mutant was observed, which is in
agreement with our results. Johnston et al. (2006) reported
that during lung infection the psaRmutant had significantly
lower bacterial loads than the wild-type after 7 days of
infection. However, in our pneumonia model, we observed
higher bacterial loads in D39DpsaR-infected mice at the
beginning of the experiment (the first 12 h). The TIGR4
DpsaR-infected mice had significantly lower bacterial loads
at 24 h only. Taking the results together, we did not observe
any clear role for PsaR during lung infection in our study.
Upon intravenous infection, we observed the most
pronounced effect of deletion of psaR. The psaR mutant
was attenuated at the early stages of blood infection. In line
with this, PsaR was identified by a large signature-tagged
mutagenesis study to be required for full virulence of a
serotype 3 strain in a bacteraemia model of infection after
24 h infection (Lau et al., 2001). Importantly, for D39 no
significant difference was observed in our model at 30 h
post-infection. This indicates that in the first 24 h PsaR
regulation is required for adaptation to the blood.
Furthermore, in D39, survival times of wild-type and
DpsaR-infected mice were different, although this just
reached statistical significance. In contrast, mice infected
with TIGR4 wild-type and DpsaR did not exhibit any
differences in the first 24 h of experimental bacteraemia,
while after 36 h they did. This indicates that in TIGR4,
PsaR contributes to the later stages of bacteraemia.
However, since the TIGR4 wild-type was not able to cause
infection as severe as D39, this contribution is considered
to be marginal.
Although we observed disturbed gene regulation in the D39
and TIGR4 mutants, in most infection models (described
above) we did not observe large effects on virulence. A study
performed on the pneumococcal carbohydrate regulator
RegM showed that, even though deletion of a regulator does
not necessarily lead to large differences in expression of
known virulence genes, it can affect pneumococcal virulence
(Giammarinaro & Paton, 2002). Conversely, a second study
by Trombe and co-workers showed that deleting the global
regulator RegR does not dramatically affect virulence, but
has a large effect on gene expression (Chapuy-Regaud et al.,
2003). It seems that the pneumococcus has several
compensatory virulence pathways.
Strain-specific contributions of genes encoding transcrip-
tional regulators have been reported previously and
complicate ascribing a general role for these genes in
transcriptional control of their targets and their contri-
bution to virulence (Hendriksen et al., 2007; McCluskey et
al., 2004). PsaR directly controls the expression of a select
group of genes individually important for virulence
(psaBCA and rlrA) (Johnston et al., 2006; Kloosterman et
al., 2008). The observed differences in PsaR-regulated gene
expression between D39 and TIGR4 might be the indirect
effect of an unbalanced Mn2+ homeostasis, which suggests
that physiological differences might reflect genetic differ-
ences present in these strains. A clear example of the
genetic difference is the rlrA pathogenicity islet, which is
strongly upregulated in TIGR4DpsaR. However, the genetic
diversity between strains only varies as much as 10%, most
of which can be attributed to the capsular genes
(Hakenbeck et al., 2001; Lanie et al., 2007). In conclusion,
PsaR does not contribute to colonization of S. pneumoniae,
but it is involved in invasive disease where it has a strain-
specific impact during both pneumonia and bacteraemia.
ACKNOWLEDGEMENTS
W.T.H. is supported by the Sophia foundation for Medical Research
(SSWO 356, Rotterdam, The Netherlands) and H. J. B. is supported
by IOP Genomics grant IGE03002 of the Dutch Ministry of Economic
Affairs. We thank Theo Hoogenboezem, Bedette van de Zande, Anne
de Jong and Lambert Lambooy for technical assistance and Tomas
Kloosterman for helpful discussion.
REFERENCES
Adrian, P. V., Thomson, C. J., Klugman, K. P. & Amyes, S. G. (2000).
New gene cassettes for trimethoprim resistance, dfr13, and
streptomycin-spectinomycin resistance, aadA4, inserted on a class 1
integron. Antimicrob Agents Chemother 44, 355–361.
Anderton, J. M., Rajam, G., Romero-Steiner, S., Summer, S.,
Kowalczyk, A. P., Carlone, G. M., Sampson, J. S. & Ades, E. W.
(2007). E-cadherin is a receptor for the common protein pneumo-
coccal surface adhesin A (PsaA) of Streptococcus pneumoniae. Microb
Pathog 42, 225–236.
Archibald, F. S. & Fridovich, I. (1981). Manganese, superoxide
dismutase, and oxygen tolerance in some lactic acid bacteria.
J Bacteriol 146, 928–936.
PsaR and pneumococcal virulence
http://mic.sgmjournals.org 1577
Blue, C. E. & Mitchell, T. J. (2003). Contribution of a response
regulator to the virulence of Streptococcus pneumoniae is strain
dependent. Infect Immun 71, 4405–4413.
Bogaert, D., De Groot, R. & Hermans, P. W. (2004). Streptococcus
pneumoniae colonisation: the key to pneumococcal disease. Lancet
Infect Dis 4, 144–154.
Briles, D. E., Ades, E., Paton, J. C., Sampson, J. S., Carlone, G. M.,
Huebner, R. C., Virolainen, A., Swiatlo, E. & Hollingshead, S. K.
(2000). Intranasal immunization of mice with a mixture of the
pneumococcal proteins PsaA and PspA is highly protective against
nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun
68, 796–800.
Chapuy-Regaud, S., Ogunniyi, A. D., Diallo, N., Huet, Y., Desnottes,
J. F., Paton, J. C., Escaich, S. & Trombe, M. C. (2003). RegR, a global
LacI/GalR family regulator, modulates virulence and competence in
Streptococcus pneumoniae. Infect Immun 71, 2615–2625.
Chastanet, A., Prudhomme, M., Claverys, J. P. & Msadek, T. (2001).
Regulation of Streptococcus pneumoniae clp genes and their role in
competence development and stress survival. J Bacteriol 183, 7295–
7307.
Chicharro, J. L., Serrano, V., Urena, R., Gutierrez, A. M., Carvajal, A.,
Fernandez-Hernando, P. & Lucia, A. (1999). Trace elements and
electrolytes in human resting mixed saliva after exercise. Br J Sports
Med 33, 204–207.
Dawid, S., Roche, A. M. & Weiser, J. N. (2007). The blp bacteriocins of
Streptococcus pneumoniae mediate intraspecies competition both in
vitro and in vivo. Infect Immun 75, 443–451.
de Saizieu, A., Gardes, C., Flint, N., Wagner, C., Kamber, M., Mitchell,
T. J., Keck, W., Amrein, K. E. & Lange, R. (2000). Microarray-based
identification of a novel Streptococcus pneumoniae regulon controlled
by an autoinduced peptide. J Bacteriol 182, 4696–4703.
Dintilhac, A., Alloing, G., Granadel, C. & Claverys, J. P. (1997).
Competence and virulence of Streptococcus pneumoniae: Adc and
PsaA mutants exhibit a requirement for Zn and Mn resulting from
inactivation of putative ABC metal permeases. Mol Microbiol 25, 727–
739.
Garcia de la Nava, J., van Hijum, S. & Trelles, O. (2003). PreP: gene
expression data pre-processing. Bioinformatics 19, 2328–2329.
Giammarinaro, P. & Paton, J. C. (2002). Role of RegM, a homologue
of the catabolite repressor protein CcpA, in the virulence of
Streptococcus pneumoniae. Infect Immun 70, 5454–5461.
Glover, D. T., Hollingshead, S. K. & Briles, D. E. (2008). Streptococcus
pneumoniae surface protein PcpA elicits protection against lung
infection and fatal sepsis. Infect Immun 76, 2767–2776.
Hakenbeck, R., Balmelle, N., Weber, B., Gardes, C., Keck, W. & de
Saizieu, A. (2001). Mosaic genes and mosaic chromosomes: intra-
and interspecies genomic variation of Streptococcus pneumoniae. Infect
Immun 69, 2477–2486.
Hanks, T. S., Liu, M., McClure, M. J., Fukumura, M., Duffy, A. & Lei, B.
(2006). Differential regulation of iron- and manganese-specific
MtsABC and heme-specific HtsABC transporters by the metallo-
regulator MtsR of group A Streptococcus. Infect Immun 74, 5132–5139.
Hava, D. L. & Camilli, A. (2002). Large-scale identification of serotype
4 Streptococcus pneumoniae virulence factors. Mol Microbiol 45, 1389–
1406.
Hava, D. L., Hemsley, C. J. & Camilli, A. (2003a). Transcriptional
regulation in the Streptococcus pneumoniae rlrA pathogenicity islet by
RlrA. J Bacteriol 185, 413–421.
Hava, D. L., LeMieux, J. & Camilli, A. (2003b). From nose to lung: the
regulation behind Streptococcus pneumoniae virulence factors. Mol
Microbiol 50, 1103–1110.
Hemsley, C., Joyce, E., Hava, D. L., Kawale, A. & Camilli, A. (2003).
MgrA, an orthologue of Mga, acts as a transcriptional repressor of the
genes within the rlrA pathogenicity islet in Streptococcus pneumoniae.
J Bacteriol 185, 6640–6647.
Hendriksen, W. T., Silva, N., Bootsma, H. J., Blue, C. E., Paterson,
G. K., Kerr, A. R., de Jong, A., Kuipers, O. P., Hermans, P. W. &
Mitchell, T. J. (2007). Regulation of gene expression in Streptococcus
pneumoniae by response regulator 09 is strain dependent. J Bacteriol
189, 1382–1389.
Hendriksen, W. T., Bootsma, H. J., Estevao, S., Hoogenboezem, T.,
de Jong, A., de Groot, R., Kuipers, O. P. & Hermans, P. W. (2008a).
CodY of Streptococcus pneumoniae: link between nutritional gene
regulation and colonization. J Bacteriol 190, 590–601.
Hendriksen, W. T., Kloosterman, T. G., Bootsma, H. J., Estevao, S.,
de Groot, R., Kuipers, O. P. & Hermans, P. W. (2008b). Site-specific
contributions of glutamine-dependent regulator GlnR and GlnR-
regulated genes to virulence of Streptococcus pneumoniae. Infect
Immun 76, 1230–1238.
Ibrahim, Y. M., Kerr, A. R., Silva, N. A. & Mitchell, T. J. (2005).
Contribution of the ATP-dependent protease ClpCP to the autolysis
and virulence of Streptococcus pneumoniae. Infect Immun 73, 730–740.
Jakubovics, N. S. & Jenkinson, H. F. (2001). Out of the iron age: new
insights into the critical role of manganese homeostasis in bacteria.
Microbiology 147, 1709–1718.
Jakubovics, N. S., Smith, A. W. & Jenkinson, H. F. (2000). Expression
of the virulence-related Sca (Mn2+) permease in Streptococcus
gordonii is regulated by a diphtheria toxin metallorepressor-like
protein ScaR. Mol Microbiol 38, 140–153.
Johnston, J. W., Myers, L. E., Ochs, M. M., Benjamin, W. H., Jr, Briles,
D. E. & Hollingshead, S. K. (2004). Lipoprotein PsaA in virulence of
Streptococcus pneumoniae: surface accessibility and role in protection
from superoxide. Infect Immun 72, 5858–5867.
Johnston, J. W., Briles, D. E., Myers, L. E. & Hollingshead, S. K.
(2006). Mn2+-dependent regulation of multiple genes in Strepto-
coccus pneumoniae through PsaR and the resultant impact on
virulence. Infect Immun 74, 1171–1180.
Kadioglu, A., Gingles, N. A., Grattan, K., Kerr, A., Mitchell, T. J. &
Andrew, P. W. (2000). Host cellular immune response to pneumo-
coccal lung infection in mice. Infect Immun 68, 492–501.
Kerr, A. R., Adrian, P. V., Estevao, S., de Groot, R., Alloing, G.,
Claverys, J. P., Mitchell, T. J. & Hermans, P. W. (2004). The Ami-AliA/
AliB permease of Streptococcus pneumoniae is involved in nasophar-
yngeal colonization but not in invasive disease. Infect Immun 72,
3902–3906.
Kloosterman, T. G., Hendriksen, W. T., Bijlsma, J. J., Bootsma, H. J.,
van Hijum, S. A., Kok, J., Hermans, P. W. & Kuipers, O. P. (2006).
Regulation of glutamine and glutamate metabolism by GlnR and
GlnA in Streptococcus pneumoniae. J Biol Chem 281, 25097–25109.
Kloosterman, T. G., van der Kooi-Pol, M. M., Bijlsma, J. J. & Kuipers,
O. P. (2007). The novel transcriptional regulator SczA mediates
protection against Zn2+ stress by activation of the Zn2+-resistance
gene czcD in Streptococcus pneumoniae. Mol Microbiol 65, 1049–1063.
Kloosterman, T. G., Witwicki, R. M., van der Kooi-Pol, M. M.,
Bijlsma, J. J. & Kuipers, O. P. (2008). Opposite effects of Mn2+ and
Zn2+ on the PsaR-mediated expression of the virulence genes pcpA,
prtA and psaBCA of Streptococcus pneumoniae. J Bacteriol 190, 5382–
5393.
Lanie, J. A., Ng, W. L., Kazmierczak, K. M., Andrzejewski, T. M.,
Davidsen, T. M., Wayne, K. J., Tettelin, H., Glass, J. I. & Winkler, M. E.
(2007). Genome sequence of Avery’s virulent serotype 2 strain D39 of
Streptococcus pneumoniae and comparison with that of unencapsu-
lated laboratory strain R6. J Bacteriol 189, 38–51.
W. T. Hendriksen and others
1578 Microbiology 155
Lau, G. W., Haataja, S., Lonetto, M., Kensit, S. E., Marra, A., Bryant,
A. P., McDevitt, D., Morrison, D. A. & Holden, D. W. (2001). A
functional genomic analysis of type 3 Streptococcus pneumoniae
virulence. Mol Microbiol 40, 555–571.
Lawrence, M. C., Pilling, P. A., Epa, V. C., Berry, A. M., Ogunniyi,
A. D. & Paton, J. C. (1998). The crystal structure of pneumococcal
surface antigen PsaA reveals a metal-binding site and a novel
structure for a putative ABC-type binding protein. Structure 6, 1553–
1561.
Long, A. D., Mangalam, H. J., Chan, B. Y., Tolleri, L., Hatfield, G. W. &
Baldi, P. (2001). Improved statistical inference from DNA microarray
data using analysis of variance and a Bayesian statistical framework.
Analysis of global gene expression in Escherichia coli K12. J Biol Chem
276, 19937–19944.
McAllister, L. J., Tseng, H. J., Ogunniyi, A. D., Jennings, M. P.,
McEwan, A. G. & Paton, J. C. (2004). Molecular analysis of the psa
permease complex of Streptococcus pneumoniae. Mol Microbiol 53,
889–901.
McCluskey, J., Hinds, J., Husain, S., Witney, A. & Mitchell, T. J. (2004).
A two-component system that controls the expression of pneumo-
coccal surface antigen A (PsaA) and regulates virulence and resistance
to oxidative stress in Streptococcus pneumoniae. Mol Microbiol 51,
1661–1675.
Paik, S., Brown, A., Munro, C. L., Cornelissen, C. N. & Kitten, T.
(2003). The sloABCR operon of Streptococcus mutans encodes an Mn
and Fe transport system required for endocarditis virulence and its
Mn-dependent repressor. J Bacteriol 185, 5967–5975.
Paterson, G. K., Blue, C. E. & Mitchell, T. J. (2006). An operon in
Streptococcus pneumoniae containing a putative alkylhydroperoxidase
D homologue contributes to virulence and the response to oxidative
stress. Microb Pathog 40, 152–160.
Polissi, A., Pontiggia, A., Feger, G., Altieri, M., Mottl, H., Ferrari, L. &
Simon, D. (1998). Large-scale identification of virulence genes from
Streptococcus pneumoniae. Infect Immun 66, 5620–5629.
Romero-Steiner, S., Pilishvili, T., Sampson, J. S., Johnson, S. E.,
Stinson, A., Carlone, G. M. & Ades, E. W. (2003). Inhibition of
pneumococcal adherence to human nasopharyngeal epithelial cells by
anti-PsaA antibodies. Clin Diagn Lab Immunol 10, 246–251.
Romero-Steiner, S., Caba, J., Rajam, G., Langley, T., Floyd, A.,
Johnson, S. E., Sampson, J. S., Carlone, G. M. & Ades, E. (2006).
Adherence of recombinant pneumococcal surface adhesin A (rPsaA)-
coated particles to human nasopharyngeal epithelial cells for the
evaluation of anti-PsaA functional antibodies. Vaccine 24, 3224–3231.
Sanchez-Beato, A. R., Lopez, R. & Garcia, J. L. (1998). Molecular
characterization of PcpA: a novel choline-binding protein of
Streptococcus pneumoniae. FEMS Microbiol Lett 164, 207–214.
Talkington, D. F., Brown, B. G., Tharpe, J. A., Koenig, A. & Russell, H.
(1996). Protection of mice against fatal pneumococcal challenge by
immunization with pneumococcal surface adhesin A (PsaA). Microb
Pathog 21, 17–22.
Tseng, H. J., McEwan, A. G., Paton, J. C. & Jennings, M. P. (2002).
Virulence of Streptococcus pneumoniae: PsaA mutants are hypersens-
itive to oxidative stress. Infect Immun 70, 1635–1639.
van Hijum, S. A., Garcia de la Nava, J., Trelles, O., Kok, J. & Kuipers,
O. P. (2003). MicroPreP: a cDNA microarray data pre-processing
framework. Appl Bioinformatics 2, 241–244.
Varrot, A., Yamamoto, H., Sekiguchi, J., Thompson, J. & Davies, G. J.
(1999). Crystallization and preliminary X-ray analysis of the 6-
phospho-alpha-glucosidase from Bacillus subtilis. Acta Crystallogr D
Biol Crystallogr 55, 1212–1214.
Edited by: T. Msadek
PsaR and pneumococcal virulence
http://mic.sgmjournals.org 1579
